New life for old HIV vaccine

Taylor Winkel

Taylor Winkel Jul 6, 2025

Feb 6, 2018

Republish Article

You can republish articles in print or online. Simply copy the HTML below, which includes our tracking pixel, all paragraph styles and hyperlinks, the author byline, and credit to Cascade PBS. Republishing of the photos or videos embedded in an article can occur only if the photo or video is a copyright of Cascade Public Media ("CPM") and not of a third party. Photos and videos that are a copyright of CPM are not required to appear in the republished article, but if they are used, they must be embedded where they appear in the original article and must include the attribution to the CPM photographer.

You may reprint in any medium
You may edit only for tense and timeliness
If republishing in print you can edit for length if you follow our print republishing guidelines.
You may write your own headline
Include a byline and shirttail with credit and link to Cascade PBS
Include our tracking pixel
Remove if we ask

          <article>
            <header>
              <hgroup>
                <h1>New life for old HIV vaccine</h1>
                <h2><p>Next year, researchers at Seattle’s Fred Hutchinson Cancer Research Center will be leading a new trial on an old HIV vaccine. According to KPLU, the vaccine was only 30 percent effective when it was first tested in Thailand back in 2003. But when researchers recently tested the same vaccine</p></h2>
              </hgroup>
               <p>By <a href="/author/taylorjwinkel-gmail-com/">Taylor Winkel</a></p> 
              <p><time datetime="2025-02-04T05:00:00-08:00">Feb 6, 2018</time></p>
            </header>
            <p>Next year, researchers at Seattle’s Fred Hutchinson Cancer Research Center will be leading a new trial on an old HIV vaccine. <a href="http://www.kplu.org/post/seattle-scientists-fresh-look-vaccine-could-be-big-break-hiv-prevention?ref=dev.cascadepbs.org">According to KPLU</a>, the vaccine was only 30 percent effective when it was first tested in Thailand back in 2003. But when researchers recently tested the same vaccine on subjects in South Africa, they got the same 30 percent result, even though the vaccine had been customized for a strain of the virus found in Thailand. The outcome gives researchers hope that their vaccine could be more effective – and versatile – than previously thought. Scientists at the Hutch, which runs the largest publicly-funded HIV vaccine trials network in the world, will launch new vaccine trials in January. — T.W.</p>
          </article>

Next year, researchers at Seattle’s Fred Hutchinson Cancer Research Center will be leading a new trial on an old HIV vaccine. According to KPLU, the vaccine was only 30 percent effective when it was first tested in Thailand back in 2003. But when researchers recently tested the same vaccine on subjects in South Africa, they got the same 30 percent result, even though the vaccine had been customized for a strain of the virus found in Thailand. The outcome gives researchers hope that their vaccine could be more effective – and versatile – than previously thought. Scientists at the Hutch, which runs the largest publicly-funded HIV vaccine trials network in the world, will launch new vaccine trials in January. — T.W.

Our members' donations make local journalism happen.

Support once for $1

Support monthly for $7

Cascade PBS Passport
Mossback members-only newsletter
Monthly Viewer Guide

Support monthly for $25

Invitation to quarterly news and original programming video conference
Annual in-person meet-up with news & programming teams
Special event perks (reduced price or free tickets, cocktails, etc.)

Continue

By Taylor Winkel

Taylor Winkel is a Journalism and Political Science student at the University of Washington. Follow her on Twitter: @twinkelnews. She can be emailed at Taylor.Winkel@crosscut.com.